Other disease model

SMC Laboratories’ nonclinical CRO portfolio

Image is for illustration purposes.Image is for illustration purposes.

SMC Laboratories has expanded its nonclinical model lineup to the fields of metabolic diseases, inflammation, fibrosis, cancer as well as Alzheimer’s disease.

Inflammation & Fibrosis

IPF

Bleomycin-induced pulmonary fibrosis

COPD

Porcine Pancreatic Elastase (PPE) model

Liver cirrhosis
CCl4-induced liver fibrosis model
Cholestatic liver diseases

Bile duct ligation (BDL) model(Click here to view a flyer)

Acute liver failure

CCl4-induced acute liver failure model

Concanavalin A-induced acute liver failure model

D-gal/LPS-induced acute liver failure model

TAA-induced acute liver failure model

CKD

UUO-induced renal fibrosis model

Adriamycin-induced nephropathy model

IBD

DSS-induced colitis model

Alzheimer’s disease

icv-STZ model

Systemic sclerosis

Bleomycin-induced skin fibrosis model

Metabolic diseases

Diabetes

nSTZ model

Fatty Liver/ NAFLD
MCD model
Fatty Liver/ NAFLD
ob/ob model

Oncology

DEN-CCl4 liver cancer model

Xenograft tumor models